BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24191928)

  • 1. [Domperidone and the risk of sudden cardiac death].
    van Roeden SE; Belle-van Meerkerk G; van Tuyl SA; van de Ree MA; Muller AF
    Ned Tijdschr Geneeskd; 2013; 157(45):A6770. PubMed ID: 24191928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.
    van Noord C; Dieleman JP; van Herpen G; Verhamme K; Sturkenboom MC
    Drug Saf; 2010 Nov; 33(11):1003-14. PubMed ID: 20925438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Domperidone: off the market or freely available?].
    Otten MH
    Ned Tijdschr Geneeskd; 2013; 157(45):A6950. PubMed ID: 24191929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the number of sudden cardiac deaths attributable to the use of domperidone in France.
    Hill C; Nicot P; Piette C; Le Gleut K; Durand G; Toussaint B
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):543-7. PubMed ID: 25832309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domperidone and sudden death.
    Prescrire Int; 2006 Dec; 15(86):226. PubMed ID: 17167933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac adverse effects of domperidone in adult patients: a systematic review].
    Marzi M; Weitz D; Avila A; Molina G; Caraballo L; Piskulic L
    Rev Med Chil; 2015 Jan; 143(1):14-21. PubMed ID: 25860264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
    Rochoy M; Auffret M; Béné J; Gautier S;
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
    Leelakanok N; Holcombe A; Schweizer ML
    Clin Drug Investig; 2016 Feb; 36(2):97-107. PubMed ID: 26649742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.
    Renoux C; Dell'Aniello S; Khairy P; Marras C; Bugden S; Turin TC; Blais L; Tamim H; Evans C; Steele R; Dormuth C; Ernst P;
    Br J Clin Pharmacol; 2016 Aug; 82(2):461-72. PubMed ID: 27062307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
    Buffery PJ; Strother RM
    N Z Med J; 2015 Jun; 128(1416):66-74. PubMed ID: 26117678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
    Prescrire Int; 2016 Oct; 25(175):238-240. PubMed ID: 30645828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domperidone: limited benefits with significant risk for sudden cardiac death.
    Hondeghem LM
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recording.
    Berger F; Saâïd S; van Gelder T; Stricker B; Becker M; van den Bemt P
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1418-1424. PubMed ID: 28924989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domperidone and sudden cardiac death: How much longer should we wait?
    Michaud V; Turgeon J
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):215-7. PubMed ID: 23328387
    [No Abstract]   [Full Text] [Related]  

  • 16. Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
    Prescrire Int; 2008 Apr; 17(94):67. PubMed ID: 18540123
    [No Abstract]   [Full Text] [Related]  

  • 17. Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies.
    Ou LB; Moriello C; Douros A; Filion KB
    Br J Clin Pharmacol; 2021 Oct; 87(10):3649-3658. PubMed ID: 33439512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study.
    Forbes N; Cooray M; Al-Dabbagh R; Yuan Y; Tse F; Liu LW; Xenodemetropoulos T
    Can J Gastroenterol Hepatol; 2016; 2016():2937678. PubMed ID: 27446835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low safety index of domperidone: mechanism for increased odds ratio for sudden cardiac death.
    Hondeghem LM
    Acta Cardiol; 2011 Aug; 66(4):421-5. PubMed ID: 21894796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label postpartum use of domperidone in Canada: a multidatabase cohort study.
    Moriello C; Paterson JM; Reynier P; Dahl M; Aibibula W; Fisher A; Gamble JM; Kuo IF; Ronksley PE; Winquist B; Filion KB;
    CMAJ Open; 2021; 9(2):E500-E509. PubMed ID: 33990364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.